vs
Side-by-side financial comparison of GE HealthCare (GEHC) and Otis Worldwide (OTIS). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.1B vs $3.6B, roughly 1.4× Otis Worldwide). Otis Worldwide runs the higher net margin — 9.5% vs 8.0%, a 1.5% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.4% vs 1.0%). Otis Worldwide produced more free cash flow last quarter ($380.0M vs $112.0M). Over the past eight quarters, GE HealthCare's revenue compounded faster (3.0% CAGR vs -0.5%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
Otis Worldwide Corporation styled as OTIS is an American company that develops, manufactures and markets elevators, escalators, moving walkways, and related equipment.
GEHC vs OTIS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.1B | $3.6B |
| Net Profit | $411.0M | $340.0M |
| Gross Margin | 38.5% | — |
| Operating Margin | 10.0% | 15.1% |
| Net Margin | 8.0% | 9.5% |
| Revenue YoY | 7.4% | 1.0% |
| Net Profit YoY | -31.0% | 39.9% |
| EPS (diluted) | $0.85 | $0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $5.1B | $3.6B | ||
| Q4 25 | $5.7B | $3.8B | ||
| Q3 25 | $5.1B | $3.7B | ||
| Q2 25 | $5.0B | $3.6B | ||
| Q1 25 | $4.8B | $3.4B | ||
| Q4 24 | $5.3B | $3.7B | ||
| Q3 24 | $4.9B | $3.5B | ||
| Q2 24 | $4.8B | $3.6B |
| Q1 26 | $411.0M | $340.0M | ||
| Q4 25 | $588.0M | $374.0M | ||
| Q3 25 | $446.0M | $374.0M | ||
| Q2 25 | $486.0M | $393.0M | ||
| Q1 25 | $564.0M | $243.0M | ||
| Q4 24 | $721.0M | $337.0M | ||
| Q3 24 | $470.0M | $540.0M | ||
| Q2 24 | $428.0M | $415.0M |
| Q1 26 | 38.5% | — | ||
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 42.1% | — | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | — | ||
| Q2 24 | 41.4% | — |
| Q1 26 | 10.0% | 15.1% | ||
| Q4 25 | 14.5% | 15.5% | ||
| Q3 25 | 12.7% | 15.9% | ||
| Q2 25 | 13.1% | 15.2% | ||
| Q1 25 | 13.2% | 12.3% | ||
| Q4 24 | 15.1% | 14.4% | ||
| Q3 24 | 13.9% | 10.2% | ||
| Q2 24 | 12.6% | 15.8% |
| Q1 26 | 8.0% | 9.5% | ||
| Q4 25 | 10.3% | 9.9% | ||
| Q3 25 | 8.7% | 10.1% | ||
| Q2 25 | 9.7% | 10.9% | ||
| Q1 25 | 11.8% | 7.3% | ||
| Q4 24 | 13.6% | 9.2% | ||
| Q3 24 | 9.7% | 15.2% | ||
| Q2 24 | 8.8% | 11.5% |
| Q1 26 | $0.85 | $0.87 | ||
| Q4 25 | $1.28 | $0.95 | ||
| Q3 25 | $0.98 | $0.95 | ||
| Q2 25 | $1.06 | $0.99 | ||
| Q1 25 | $1.23 | $0.61 | ||
| Q4 24 | $1.58 | $0.85 | ||
| Q3 24 | $1.02 | $1.34 | ||
| Q2 24 | $0.93 | $1.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $834.0M |
| Total DebtLower is stronger | $10.1B | $6.9B |
| Stockholders' EquityBook value | $10.7B | — |
| Total Assets | $37.1B | $10.5B |
| Debt / EquityLower = less leverage | 0.95× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $834.0M | ||
| Q4 25 | $4.5B | $1.1B | ||
| Q3 25 | $4.0B | $840.0M | ||
| Q2 25 | $3.7B | $688.0M | ||
| Q1 25 | $2.5B | $1.9B | ||
| Q4 24 | $2.9B | $2.3B | ||
| Q3 24 | $3.5B | $827.0M | ||
| Q2 24 | $2.0B | $942.0M |
| Q1 26 | $10.1B | $6.9B | ||
| Q4 25 | $10.0B | $7.8B | ||
| Q3 25 | $10.3B | $7.7B | ||
| Q2 25 | $10.3B | $7.2B | ||
| Q1 25 | $8.8B | $8.4B | ||
| Q4 24 | $9.0B | $8.3B | ||
| Q3 24 | $10.3B | $6.9B | ||
| Q2 24 | $9.2B | $6.8B |
| Q1 26 | $10.7B | — | ||
| Q4 25 | $10.4B | $-5.4B | ||
| Q3 25 | $10.0B | $-5.4B | ||
| Q2 25 | $9.7B | $-5.4B | ||
| Q1 25 | $9.2B | $-5.1B | ||
| Q4 24 | $8.4B | $-4.8B | ||
| Q3 24 | $8.3B | $-4.9B | ||
| Q2 24 | $7.8B | $-5.0B |
| Q1 26 | $37.1B | $10.5B | ||
| Q4 25 | $36.9B | $10.7B | ||
| Q3 25 | $36.1B | $10.8B | ||
| Q2 25 | $35.5B | $10.5B | ||
| Q1 25 | $33.6B | $11.2B | ||
| Q4 24 | $33.1B | $11.3B | ||
| Q3 24 | $33.9B | $10.3B | ||
| Q2 24 | $31.9B | $9.9B |
| Q1 26 | 0.95× | — | ||
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.18× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | $112.0M | $380.0M |
| FCF MarginFCF / Revenue | 2.2% | 10.7% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.7B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $817.0M | ||
| Q3 25 | — | $374.0M | ||
| Q2 25 | $94.0M | $215.0M | ||
| Q1 25 | $250.0M | $190.0M | ||
| Q4 24 | — | $690.0M | ||
| Q3 24 | — | $394.0M | ||
| Q2 24 | $-119.0M | $308.0M |
| Q1 26 | $112.0M | $380.0M | ||
| Q4 25 | — | $772.0M | ||
| Q3 25 | — | $337.0M | ||
| Q2 25 | $8.0M | $179.0M | ||
| Q1 25 | $98.0M | $156.0M | ||
| Q4 24 | — | $651.0M | ||
| Q3 24 | — | $362.0M | ||
| Q2 24 | $-183.0M | $284.0M |
| Q1 26 | 2.2% | 10.7% | ||
| Q4 25 | — | 20.3% | ||
| Q3 25 | — | 9.1% | ||
| Q2 25 | 0.2% | 5.0% | ||
| Q1 25 | 2.1% | 4.7% | ||
| Q4 24 | — | 17.7% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | -3.8% | 7.9% |
| Q1 26 | — | 0.9% | ||
| Q4 25 | 2.4% | 1.2% | ||
| Q3 25 | 2.1% | 1.0% | ||
| Q2 25 | 1.7% | 1.0% | ||
| Q1 25 | 3.2% | 1.0% | ||
| Q4 24 | 1.9% | 1.1% | ||
| Q3 24 | 1.9% | 0.9% | ||
| Q2 24 | 1.3% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.18× | ||
| Q3 25 | — | 1.00× | ||
| Q2 25 | 0.19× | 0.55× | ||
| Q1 25 | 0.44× | 0.78× | ||
| Q4 24 | — | 2.05× | ||
| Q3 24 | — | 0.73× | ||
| Q2 24 | -0.28× | 0.74× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
OTIS
| Service | $2.4B | 68% |
| New Equipment | $1.1B | 32% |
